Health
COVID-19 Testing Stocks Move Lower After Abbott Receives EUA For 15-Minute Test – Benzinga
Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen …
Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen test.
Abbott’s BinaxNOW could be transformative, Morgan Stanley analyst David Lewis said in a note.
The test is bigger and better than expected, given the $5 price point; the fact that it’s a nasal swab; its better-than-expected performance; and a higher shipment volume, the analyst said.
The Sympathy Move: The announcement, though catalyzing…
-
General11 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News20 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News11 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News10 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years